For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Seelos Therapeutics Inc (NASDAQ: SEEL) closed at $0.67 in the last session, down -7.78% from day before closing price of $0.73. In other words, the price has decreased by -$7.78 from its previous closing price. On the day, 1.8 million shares were traded. SEEL stock price reached its highest trading level at $0.77 during the session, while it also had its lowest trading level at $0.6119.
Ratios:
We take a closer look at SEEL’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 0.10 and its Current Ratio is at 0.10.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, ROTH Capital on September 27, 2021, Upgraded its rating to Buy and sets its target price to $8 from $2.50 previously.
On July 01, 2021, Guggenheim started tracking the stock assigning a Buy rating and target price of $8.
On June 01, 2021, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $10.Cantor Fitzgerald initiated its Overweight rating on June 01, 2021, with a $10 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Dec 01 ’23 when Mehra Raj bought 75,757 shares for $1.32 per share. The transaction valued at 99,999 led to the insider holds 185,142 shares of the business.
Golembiewski Michael Joseph bought 83,000 shares of SEEL for $100,222 on Nov 30 ’23. The Chief Financial Officer now owns 86,450 shares after completing the transaction at $1.21 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SEEL now has a Market Capitalization of 1916046 and an Enterprise Value of 14068964. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.97. Its current Enterprise Value per Revenue stands at 7.127.
Stock Price History:
The Beta on a monthly basis for SEEL is 1.91, which has changed by -0.9978851 over the last 52 weeks, in comparison to a change of 0.23951602 over the same period for the S&P500. Over the past 52 weeks, SEEL has reached a high of $398.40, while it has fallen to a 52-week low of $0.47. The 50-Day Moving Average of the stock is -50.84%, while the 200-Day Moving Average is calculated to be -95.27%.
Shares Statistics:
According to the various share statistics, SEEL traded on average about 421.87K shares per day over the past 3-months and 2020930 shares per day over the past 10 days. A total of 2.86M shares are outstanding, with a floating share count of 2.69M. Insiders hold about 5.83% of the company’s shares, while institutions hold 11.48% stake in the company. Shares short for SEEL as of 1718323200 were 215571 with a Short Ratio of 0.32, compared to 1715731200 on 98223. Therefore, it implies a Short% of Shares Outstanding of 215571 and a Short% of Float of 7.630000000000001.
